Mitigation Strategies for US and EU Supply Chain Risk Introduced by COVID-19

On-Demand Webinar

The current global health crisis has a profound effect on the pharmaceutical supply chain, from raw materials to clinical supply, to store shelves. This 30-minute talk and Q&A summarized the FDA and EMA recommendations and guidance regarding these challenges and provided our perspective on industry approaches.

You must be registered on AAPS to VIEW HERE.